Response prediction to neoadjuvant chemotherapy
We investigated whether we could identify gene expression profiles in initial core biopsies of breast cancer samples that would permit to a) predict a clinically meaningful response to Epi/Doc in terms of tumor size reduction, b) predict a profound reduction in intratumoral Ki67 protein expression, and c) predict an in vitro response to Epi/Doc in the ATP-TCA.
Cancer Type: Breast Cancer
GPL: 96
Number of Genes with Data: 978
Number Observations: 22
Number Outputs: 3
Imbalanced Ratio: 0.833333333
Default Task: Classification